Tessenderlo completes sale of pharmaceutical ingredients business

Tessenderlo Group (Brussels) says it has completed the previously announced sale of its pharmaceutical ingredients subsidiaries Calaire Chimie (Calais, France) and Farchemia (Treviglio, Italy) to the International Chemical Investors Group, a private industrial holding company. Plans for the sale were announced last October. Information and consultation procedures were completed in early November, and following clearance by the merger control authorities, the sale was completed on 5 December, Tessenderlo says. The divestment is in line with Tessenderlo’s...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers